Prepare for your visit

Jennifer H Cho

Optometrist · Wyomissing, PA · NPI 1619204112

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$4,432.71

in general payments reported to CMS, 2019-2025 · $1,187 in 2025

The $1,187 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).

Who reported paying

General payments only, top 6 by amount.

Tarsus Pharmaceuticals, INC. $899.12
Abbvie INC. $688.98
Coopervision INC. $342.71
Allergan, INC. $332.02
Lkc Technologies, INC. $321.35
Bausch & Lomb Americas INC. $301.26

Drugs and devices associated with these payments

Xdemvy Vuity Xiidra Xen Glaucoma Treatment System Durysta Izervay Miebo Oxervate Lumigan Myday Contact Lens Infuse Vevye

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Jennifer Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1206384/jennifer-h-cho